医学
氨甲环酸
相对风险
荟萃分析
安慰剂
随机对照试验
输血
置信区间
产科
怀孕
麻醉
失血
外科
内科学
病理
替代医学
生物
遗传学
作者
Amy Lee,Mary Ying-Fang Wang,Debosree Roy,Jenny Wang,Abha Gokhale,Lauren Miranda-Cacdac,Moriah Kuntz,Bryan Grover,Kendra Gray,Kathleen L. Curley
出处
期刊:American Journal of Perinatology
[Georg Thieme Verlag KG]
日期:2023-06-13
卷期号:41 (S 01): e2254-e2268
被引量:2
摘要
Postpartum hemorrhage (PPH) is the leading cause of maternal mortality worldwide and PPH resulting in transfusion is the most common maternal morbidity in the United States. Literature demonstrates that tranexamic acid (TXA) can reduce blood loss in cesarean deliveries; however, there is little consensus on the impact on major morbidities like PPH and transfusions. We conducted a systematic review/meta-analysis of randomized controlled trials (RCTs) to evaluate if administration of prophylactic intravenous (IV) TXA prevents PPH and/or transfusions following low-risk cesarean delivery. PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-analyses) guidelines were followed. Five databases were searched: Cochrane, EBSCO, Ovid, PubMed, and ClinicalKey. RCTs published in English between January 2000 and December 2021 were included. Studies compared PPH and transfusions in cesarean deliveries between prophylactic IV TXA and control (placebo or no placebo). The primary outcome was PPH, and the secondary outcome was transfusions. Random effects models were used to calculate effect size (ES) of exposure in Mantel–Haenszel risk ratios (RR). All analysis was done at a confidence level (CI) of α = 0.5. Modeling showed that TXA led to significantly less risk of PPH than control (RR: 0.43; 95% CI: 0.28–0.67). The effect on transfusion was comparable (RR: 0.39; 95% CI: 0.21–0.73). Heterogeneity was minimal (I 2 = 0%). Due to the large sample sizes needed, many RCTs are not powered to interpret TXA's effect on PPH and transfusions. Pooling these studies in a meta-analysis allows for more power and analysis but is limited by the heterogeneity of studies. Our results minimize heterogeneity while demonstrating that prophylactic TXA can lower PPH occurrence and reduce the need for blood transfusion. We suggest considering prophylactic IV TXA as the standard of care in low-risk cesarean deliveries. Key Points
科研通智能强力驱动
Strongly Powered by AbleSci AI